ZA884505B - 8alpha-acylaminoergoline,its preparation and pharmaceutical compositions containing it - Google Patents

8alpha-acylaminoergoline,its preparation and pharmaceutical compositions containing it

Info

Publication number
ZA884505B
ZA884505B ZA884505A ZA884505A ZA884505B ZA 884505 B ZA884505 B ZA 884505B ZA 884505 A ZA884505 A ZA 884505A ZA 884505 A ZA884505 A ZA 884505A ZA 884505 B ZA884505 B ZA 884505B
Authority
ZA
South Africa
Prior art keywords
acylaminoergoline
8alpha
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
ZA884505A
Other languages
English (en)
Inventor
Walter Haefliger
Haefliger Walter
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA884505B publication Critical patent/ZA884505B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/10Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hetero atoms directly attached in position 8
    • C07D457/12Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/48Ergoline derivatives, e.g. lysergic acid, ergotamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
ZA884505A 1987-06-23 1988-06-23 8alpha-acylaminoergoline,its preparation and pharmaceutical compositions containing it ZA884505B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3720656 1987-06-23

Publications (1)

Publication Number Publication Date
ZA884505B true ZA884505B (en) 1990-02-28

Family

ID=6330087

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA884505A ZA884505B (en) 1987-06-23 1988-06-23 8alpha-acylaminoergoline,its preparation and pharmaceutical compositions containing it

Country Status (28)

Country Link
US (1) US5075318A (nl)
JP (1) JPH0670052B2 (nl)
KR (1) KR970001527B1 (nl)
AT (1) AT395242B (nl)
AU (1) AU615657B2 (nl)
BE (1) BE1004034A3 (nl)
CA (1) CA1302404C (nl)
CH (1) CH674646A5 (nl)
CY (1) CY1752A (nl)
DK (1) DK169335B1 (nl)
ES (1) ES2010282A6 (nl)
FI (1) FI88302C (nl)
FR (1) FR2617166B1 (nl)
GB (1) GB2206115B (nl)
GR (1) GR1002318B (nl)
HK (1) HK2794A (nl)
HU (2) HU203097B (nl)
IE (1) IE60550B1 (nl)
IL (1) IL86820A (nl)
IT (1) IT1219652B (nl)
LU (1) LU87251A1 (nl)
MY (1) MY103584A (nl)
NL (1) NL8801597A (nl)
NZ (1) NZ225112A (nl)
PH (1) PH24690A (nl)
PT (1) PT87781B (nl)
SE (1) SE467925B (nl)
ZA (1) ZA884505B (nl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
JP3630888B2 (ja) * 1996-10-31 2005-03-23 株式会社ニデック レンズ搬送装置と眼鏡レンズを搬送するための眼鏡レンズ用固定カップ及びレンズ搬送方法
JP6265583B2 (ja) 2008-10-17 2018-01-24 ウィスコンシン アルムニ リサーチ ファンデイション 生理活性アルファベータペプチドを作製する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL193541C (nl) * 1984-01-12 2000-01-04 Novartis Ag 8 Alfa-acylaminoergolinen, werkwijzen voor de bereiding daarvan en preparaten die ze bevatten.
CH666035A5 (de) * 1984-12-24 1988-06-30 Sandoz Ag 8-alpha-acylaminoergolene.

Also Published As

Publication number Publication date
HU203097B (en) 1991-05-28
HU211651A9 (en) 1995-12-28
IL86820A (en) 1991-07-18
FI88302C (fi) 1993-04-26
FR2617166A1 (fr) 1988-12-30
CA1302404C (en) 1992-06-02
CY1752A (en) 1994-06-03
DK340188D0 (da) 1988-06-21
IL86820A0 (en) 1988-11-30
MY103584A (en) 1993-08-28
GR880100401A (el) 1989-03-08
FR2617166B1 (fr) 1992-07-17
US5075318A (en) 1991-12-24
IE881867L (en) 1988-12-23
FI883008A0 (fi) 1988-06-22
DK169335B1 (da) 1994-10-10
PT87781B (pt) 1992-10-30
BE1004034A3 (fr) 1992-09-15
KR890000479A (ko) 1989-03-14
KR970001527B1 (ko) 1997-02-11
SE8802323L (sv) 1988-12-24
ES2010282A6 (es) 1989-11-01
GR1002318B (el) 1996-05-13
HUT50174A (en) 1989-12-28
IE60550B1 (en) 1994-07-27
IT8848097A0 (it) 1988-06-17
JPS6422876A (en) 1989-01-25
IT1219652B (it) 1990-05-24
SE8802323D0 (sv) 1988-06-21
FI883008A (fi) 1988-12-24
NL8801597A (nl) 1989-01-16
AT395242B (de) 1992-10-27
HK2794A (en) 1994-01-21
DK340188A (da) 1988-12-24
LU87251A1 (fr) 1989-03-08
GB2206115A (en) 1988-12-29
GB8814615D0 (en) 1988-07-27
PH24690A (en) 1990-09-07
GB2206115B (en) 1991-04-03
FI88302B (fi) 1993-01-15
JPH0670052B2 (ja) 1994-09-07
AU1819488A (en) 1989-01-05
SE467925B (sv) 1992-10-05
PT87781A (pt) 1989-05-31
AU615657B2 (en) 1991-10-10
NZ225112A (en) 1991-03-26
CH674646A5 (nl) 1990-06-29
ATA161788A (de) 1992-03-15

Similar Documents

Publication Publication Date Title
IL84723A0 (en) Substituted basic 2-amino-tetralins,their preparation and pharmaceutical compositions containing them
IL95155A0 (en) 1h-indazole-3-carboxamides,their preparation and pharmaceutical compositions containing them
IL95640A0 (en) 1-cycloalkylpiperidines,their preparation and pharmaceutical compositions containing them
IL81930A0 (en) Oxadiazoles,their preparation and pharmaceutical compositions containing them
IL82671A0 (en) 1,5-diaryl-3-substituted-pyrazoles,their preparation and pharmaceutical compositions containing them
IL81322A0 (en) Thieno-1,4-diazepines,their preparation and pharmaceutical compositions containing them
IL84302A0 (en) Substituted alpha-aminoacids,their preparation and pharmaceutical compositions containing them
IL94556A0 (en) Hydroxypropylamines,their preparation and pharmaceutical compositions containing them
IL84060A0 (en) Imidazobenzoxazinones,their preparation and pharmaceutical compositions containing them
IL87644A0 (en) Oxadiazolyl-azabicycloheptanes,their preparation and pharmaceutical compositions containing them
IL88404A0 (en) Neutrophil activating factor,its preparation and pharmaceutical compositions containing it
IL91709A0 (en) Substituted thienopyrans,their preparation and pharmaceutical compositions containing them
GB2201676B (en) Piperazinecarboxylic acid, its preparation and pharmaceutical compositions containing it
IL86478A (en) Substituted vinylcephalosporins, their preparation and pharmaceutical compositions containing them
IL92326A0 (en) Substituted oxadiamino-butanes,their preparation and pharmaceutical compositions containing them
IL86926A0 (en) 1h-pyrazole-1-alkanamides,their preparation and pharmaceutical compositions containing them
IL85612A0 (en) 4-phenylpiperidine compounds,their preparation and pharmaceutical compositions containing them
IL88743A0 (en) Soluble recombinant fcepsilon-receptor,its preparation and pharmaceutical compositions containing it
IL95563A0 (en) Substituted amino-pyridines,their preparation and pharmaceutical compositions containing them
IL84509A0 (en) Pyrrolo-benzimidazoles,their preparation and pharmaceutical composition containing them
GB2206115B (en) 8a-acylaminoergoline, its preparation and pharmaceutical compositions containing it
IL85824A0 (en) Pyrrolealdehydes,their preparation and pharmaceutical compositions containing them
IL88673A0 (en) N-hydroxy-5-phenyl-2-furancarboxi-midamides,and pharmaceutical compositions containing them
IL84633A0 (en) 1-aryloxy-3-amino-2-propanols,their preparation and pharmaceutical compositions containing them
IL81671A0 (en) Substituted pyrimidoindoles,their preparation and pharmaceutical compositions containing them